Company research / Focus view

Sun Pharmaceutical

SUNPHARMA · Pharma & Healthcare · large cap · Sensex 30 · Nifty 50

Revenue · FY26

₹58,220 cr

+11.9% YoY

What the business sold

Net profit · FY26

₹11,479 cr

+5.0% YoY

What it kept after tax

Operating profit · FY26

₹13,595 cr

+8.1% YoY

Profit from operations

Operating cash flow · FY26

₹12,419 cr

-11.7% YoY

Cash the operations produced

Total debt · FY26

₹4,627 cr

+95.9% YoY

Borrowings against the business

Dividend per share · FY26

—

Paid out per share · not collected yet

Five years in perspective

Price index · Start = 100 · Dividends excluded · ₹1,840 today (-1.13%)

+137.0% · 5Y

2021 · 10020222023202420252026 · 231.4

1M -5.3%6M +0.8%1Y +14.3%3Y +61.8%5Y +137.0%

Market cap

₹4.41 L Cr

As of 13 Sept 2026

Price to earnings

36.5

Price to book 5.3

Dividend yield

87.00%

Trailing twelve months

52-week range

₹1,548 – ₹2,047

Closing prices

The financial record

₹ crore · Consolidated where reported · Indian fiscal years (April–March)

Reported metric	FY23	FY24	FY25	FY26
Revenue	43,279	47,758	52,041	58,220
Operating profit	9,277	10,468	12,581	13,595
Net profit	8,474	9,576	10,929	11,479
Operating cash flow	4,959	12,135	14,072	12,419
Free cash flow	2,874	9,933	11,944	8,810
Capital expenditure	-2,086	-2,202	-2,129	-3,609
Tax expense	848	1,439	2,772	3,554
Total debt	6,886	3,274	2,362	4,627
Cash and equivalents	4,624	9,286	10,269	9,771
Shareholders equity	55,995	63,667	72,218	83,570
Earnings per share (₹)	35.30	39.90	45.60	47.80

Not collected yet for this company: Dividend per share. These come from the filings, not the daily price feed.

Recent quarters

₹ crore · Most recent first

Quarter ended	Revenue	Operating profit	Net profit	EPS (₹)
30 Jun 2026	15,184	3,557	2,895	12.10
31 Mar 2026	14,560	2,752	2,714	11.30
31 Dec 2025	15,469	4,062	3,369	14.00
30 Jun 2025	13,786	3,372	2,279	9.50
31 Mar 2025	12,816	2,761	2,150	9.00

Developments

0 positive · 0 negative

Neutral2 days ago

Sun Pharma Subsidiaries Settle with Plaintiff in US Generic Drug Pricing Litigation

Sun Pharmaceuticallarge cap

Medical Dialogues12 Sept 2026, 9:30 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Sun Pharma subsidiaries settle US generic drug pricing antitrust case for confidential amount

Sun Pharmaceuticallarge cap

CNBC TV1811 Sept 2026, 8:47 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Sun Pharmaceutical Industries falls Friday, underperforms competitors

Sun Pharmaceuticallarge cap

MarketWatch11 Sept 2026, 4:02 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

IOL Chemicals And Pharmaceuticals (IOLCP) Share Price Falls 8.19% Today

Sun Pharmaceuticallarge cap

Univest11 Sept 2026, 3:27 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral3 days ago

Sun Pharma may not announce any dividends, buybacks between FY27-29 - Bernstein explains why

Sun Pharmaceuticallarge cap

CNBC TV1811 Sept 2026, 8:23 am IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralEarnings4 days ago

Buy, Sell Or Hold: NMDC, Ola Electric, BEL, Ather Energy And Sun Pharma — Ask Profit

NMDCmid cap Bharat ElectronicsMentioned Sun PharmaceuticalMentioned

NDTV Profit10 Sept 2026, 10:08 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Sun Pharma incorporates global treasury arm at IFSC, GIFT City

Sun Pharmaceuticallarge cap

ET Manufacturing9 Sept 2026, 7:50 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Nifty Pharma Prediction for Tomorrow: 10 Sep 2026

Sun Pharmaceuticallarge cap

Univest9 Sept 2026, 4:21 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Sun Pharma acquires GIFT City treasury unit for ₹9.50 crore

Sun Pharmaceuticallarge cap

scanx.trade9 Sept 2026, 3:50 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Sun Pharmaceutical Industries Ltd drops for fifth straight session

Sun Pharmaceuticallarge cap

Business Standard9 Sept 2026, 2:35 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Stocks to watch: Sun Pharma, Suzlon Energy, OMCs, Biocon, IHCL, Tata Power

Suzlon Energymid cap Indian Hotels CompanyMentioned Sun PharmaceuticalMentioned Tata PowerMentioned

Business Standard9 Sept 2026, 8:09 am IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral5 days ago

Stocks To Watch Today: Bajaj Finance, Tata Communications, PVR Inox, Avenue Super Marts, Bank of Baroda and Sun Pharma & More

Bajaj Financelarge cap Bank of BarodaMentioned PVR INOXMentioned Sun PharmaceuticalMentioned

NDTV Profit9 Sept 2026, 7:01 am IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Sun Pharma gets ratings boost from Moody's, S&P over $11.75-bn Organon bid

Sun Pharmaceuticallarge cap

Business Standard8 Sept 2026, 7:06 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Sun Pharma gets ratings boost from Moody's, S&P over $11.75 bn Organon & Co acquisition bid

Sun Pharmaceuticallarge cap

ET Manufacturing8 Sept 2026, 4:30 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Sun Pharmaceutical Industries slips Tuesday, underperforms market

Sun Pharmaceuticallarge cap

MarketWatch8 Sept 2026, 4:02 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Moody's Ratings Assigns Baa1 Long-Term Issuer Rating To Sun Pharmaceutical Industries

Sun Pharmaceuticallarge cap

TradingView8 Sept 2026, 1:38 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Moody's Ratings assigns Baa1 rating to Sun Pharma; outlook stable

Sun Pharmaceuticallarge cap

TradingView8 Sept 2026, 1:36 pm IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

Sun Pharma incorporates global treasury arm at IFSC, GIFT City

Sun Pharmaceuticallarge cap

The Economic Times8 Sept 2026, 12:30 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

Neutral6 days ago

More Indian pharma exporters may follow Sun Pharma on US MFN pricing to bypass tariff

Sun Pharmaceuticallarge cap

The New Indian Express8 Sept 2026, 12:06 am IST

Classification & context · Moves the numbers

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

Names an event that should show up in revenue, profit, debt, capacity or approvals.

Classifier confidence: 0.35. This is not the probability that the report is true.

NeutralOrders7 days ago

Sun Pharma seals deal with US government

Sun Pharmaceuticallarge cap

Pharmacy Business7 Sept 2026, 6:34 pm IST

Classification & context · Routine

No supported direction in the headline — that is not the same as unimportant. This classifies the headline only, not the full article. It is not a recommendation.

A real announcement — a product, a partnership, an appearance — that is unlikely to change the financials.

Classifier confidence: 0.35. This is not the probability that the report is true.

About the business

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; specialty medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers generics and APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.

Industry: Drug Manufacturers - Specialty & Generic

sunpharma.com

Data confidence

Prices, fundamentals and developments last verified 13 Sept 2026. Fundamentals are sourced from public filings feeds; interpretation is shown separately from figures.

See the Pharma & Healthcare sector →

Sign in to see the full financial record and classified developments

Guests see a sample. Members get every company, five-year fundamentals, classified developments, a watchlist and the decision journal.